Literature DB >> 2088201

Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis.

T E Herchline1, J Barnishan, L W Ayers, R J Fass.   

Abstract

Of 59 clinical isolates of Staphylococcus lugdunensis, 76% were beta-lactamase negative, with penicillin G MICs of less than or equal to 0.13 microgram/ml, and 24% were beta-lactamase positive, with penicillin MICs of greater than or equal to 0.5 microgram/ml. Bimodal distributions were observed also with ampicillin, ampicillin-sulbactam, and amoxicillin-clavulanate. All strains were susceptible to oxacillin, cephalothin, gentamicin, rifampin, and vancomycin; 98% were erythromycin susceptible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088201      PMCID: PMC172078          DOI: 10.1128/AAC.34.12.2434

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors:  R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

2.  Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents.

Authors:  J Fleurette; M Bès; Y Brun; J Freney; F Forey; M Coulet; M E Reverdy; J Etienne
Journal:  Res Microbiol       Date:  1989-02       Impact factor: 3.992

  2 in total
  12 in total

1.  Staphylococcus lugdunensis endocarditis--the hidden peril of coagulase-negative staphylococcus in blood cultures.

Authors:  M H Seenivasan; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-04       Impact factor: 3.267

2.  Right-sided endocarditis due to Staphylococcus lugdunensis: First reported case.

Authors:  C Cooper; S Choudhri; R Hoeschen
Journal:  Can J Infect Dis       Date:  1998-07

3.  Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.

Authors:  Ian H McHardy; Jennifer Veltman; Janet Hindler; Katia Bruxvoort; Marissa M Carvalho; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

4.  Frequency of isolation of Staphylococcus lugdunensis in consecutive urine cultures and relationship to urinary tract infection.

Authors:  D T Haile; J Hughes; E Vetter; P Kohner; R Snyder; R Patel; F R Cockerill
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections.

Authors:  Neel B Shah; Douglas R Osmon; Hind Fadel; Robin Patel; Peggy C Kohner; James M Steckelberg; Tad Mabry; Elie F Berbari
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

6.  In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.

Authors:  Kristi L Frank; Emily J Reichert; Kerryl E Piper; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

7.  Vertebral osteomyelitis due to Staphylococcus lugdunensis.

Authors:  D R Murdoch; R J Everts; S T Chambers; I A Cowan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.

Authors:  Michael Petzsch; Werner Leber; Bernd Westphal; Sabine Crusius; Emil C Reisinger
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

9.  Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis.

Authors:  C Chiquet; A Pechinot; C Creuzot-Garcher; Y Benito; J Croize; S Boisset; J P Romanet; G Lina; F Vandenesch
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

10.  Staphylococcus lugdunensis endocarditis.

Authors:  R Shuttleworth; W D Colby
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.